通过人工智能识别出FDA批准的药物, 可以延长ALS患者的生活. AI identifies FDA-approved drugs that could extend ALS patients' lives.

研究人员利用人工智能识别出已获FDA批准的药物, 可以延长ALS患者的生活. Researchers used artificial intelligence to identify existing FDA-approved drugs that could extend the lives of ALS patients. 人工智能发现了几种候选药物,包括一种类风湿性关节炎的药物.目前正在临床试验中进行测试以评估它们在治疗疾病中的潜在有效性. The AI discovered several candidates, including a rheumatoid arthritis drug, which are currently being tested in clinical trials to evaluate their potential effectiveness in treating the disease.